Skip to main content
. 2021 Aug 11;9(8):996. doi: 10.3390/biomedicines9080996
3CLpro 3C-like protease
CoV coronavirus
COVID-19 coronavirus disease 2019
C-term C-terminal
FDA Food and Drug Administration
FLuc firefly luciferase
HBV hepatitis B virus
HDV hepatitis delta virus
HIV human immunodeficiency virus
HSV herpes simplex virus
HTS high-throughput screening
IRES internal ribosome entry site
MERS Middle East respiratory syndrome
NLuc Nano-glo® luciferase
NSP Nonstructural proteins
NTP Nucleoside triphosphate
N-term N-terminal
ORF open reading frame
PLpro papain-like protease
RdRp RNA-dependent RNA polymerase
SARS severe acute respiratory syndrome
SARS-CoV-2 severe acute respiratory syndrome coronavirus 2
UTR untranslated region